Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf-liver microsomes.
D000117:Acetylglucosamine / Q000031:analogs & derivatives / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002417:Cattle; D002845:Chromatography; D002848:Chromatography, DEAE-Cellulose; D006156:Guanosine Diphosphate Sugars / Q000378:metabolism; D006598:Hexosediphosphates / Q000378:metabolism*; D007700:Kinetics; D008358:Mannose / Q000378:metabolism; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism*; D012822:Silicon Dioxide; D013729:Terpenes / Q000378:metabolism; D013997:Time Factors; D014537:Uridine Diphosphate N-Acetylglucosamine / Q000378:metabolism; D014539:Uridine Diphosphate Sugars / Q000378:metabolism
D000900:Anti-Bacterial Agents; D006156:Guanosine Diphosphate Sugars; D006598:Hexosediphosphates; D013729:Terpenes; D014539:Uridine Diphosphate Sugars; D014537:Uridine Diphosphate N-Acetylglucosamine; D012822:Silicon Dioxide; D008358:Mannose; D000117:Acetylglucosamine